Iovance Biotherapeutics target price raised to $11 from $6 by Baird
IOVA•Baird raised its target price for Iovance Biotherapeutics to $11 from $6.
Related News
Press digest: Wall Street Journal — October 8
ORCL•
TD Cowen resumes Citigroup coverage with buy versus hold rating; target price $150 versus $130
C•
Texas Capital Bancshares: Jefferies cuts target price to $100 from $105
TCBI•
Italy - Factors to watch on October 8
SPY•
KBW cuts Franklin Templeton target price to $37 from $38
BEN•